(2 R,6 R)-Hydroxynorketamine Exerts mGluR2-Dependent Antidepressant Actions

被引：0
|
作者：
Zanos, Panos [1 ]
Highland, Jaclyn [1 ]
Georgiou, Polymnia [1 ]
Stewart, Brent [1 ]
Bonaventura, Jordi [1 ]
Lam, Sherry [1 ]
Zarate, Carlos, Jr. [1 ]
Michaelides, Michael [1 ]
Gould, Todd [1 ]
机构：
[1] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2018年 / 43卷
关键词：
Ketamine; Hydroxynorketamine; Depression; Antidepressant; mGlu; 2/3; Receptor;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
T31
引用
收藏
页码：S243 / S243
页数：1
相关论文
共 50 条
  • [31] Common Neurotransmission Recruited in (R,S)-Ketamine and (2R, 6R)-Hydroxynorketamine-Induced Sustained Antidepressant-like Effects
    Thu Ha Pham
    Defaix, Celine
    Xu, Xiaoming
    Deng, Shi-Xian
    Fabresse, Nicolas
    Alvarez, Jean-Claude
    Landry, Donald W.
    Brachman, Rebecca A.
    Denny, Christine A.
    Gardier, Alain M.
    BIOLOGICAL PSYCHIATRY, 2018, 84 (01) : E3 - E6
  • [32] Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function
    Lumsden, Eric W.
    Troppoli, Timothy A.
    Myers, Scott J.
    Zanos, Panos
    Aracava, Yasco
    Kehr, Jan
    Lovett, Jacqueline
    Kim, Sukhan
    Wang, Fu-Hua
    Schmidt, Staffan
    Jenne, Carleigh E.
    Yuan, Peixiong
    Morris, Patrick J.
    Thomas, Craig J.
    Zarate, Carlos A., Jr.
    Moaddel, Ruin
    Traynelis, Stephen F.
    Pereira, Edna F. R.
    Thompson, Scott M.
    Albuquerque, Edson X.
    Gould, Todd D.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (11) : 5160 - 5169
  • [33] Common neurotransmission recruited in (R,S)-ketamine and (2R,6R)-hydroxynorketamine-induced sustained antidepressant-like effects
    Pham, T. H.
    Defaix, C.
    Xu, X.
    Deng, S. X.
    Landry, D. W.
    Brachman, R. A.
    Denny, C. A.
    Gardier, A. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S1000 - S1001
  • [34] The Ketamine Metabolite 2R,6R-Hydroxynorketamine Blocks NMDA Receptors and Impacts Downstream Signaling Linked to Antidepressant Effects
    Ege T Kavalali
    Lisa M Monteggia
    Neuropsychopharmacology, 2018, 43 : 221 - 222
  • [35] Synaptic Mechanisms by Which (2R,6R)-Hydroxynorketamine Promotes Hippocampal-Dependent Plasticity and Behavior
    Riggs, Lace
    Mou, Ta-Chung
    Aronson, Sage
    Aracava, Yasco
    An, Xiaoxian
    Pereira, Edna
    Thompson, Scott
    Gould, Todd
    BIOLOGICAL PSYCHIATRY, 2022, 91 (09) : S244 - S245
  • [36] Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors
    Joseph, Thomas T.
    Bu, Weiming
    Lin, Wenzhen
    Zoubak, Lioudmila
    Yeliseev, Alexei
    Liu, Renyu
    Eckenhoff, Roderic G.
    Brannigan, Grace
    ACS CHEMICAL NEUROSCIENCE, 2021, 12 (09): : 1487 - 1497
  • [37] The Ketamine Metabolite 2R,6R-Hydroxynorketamine Blocks NMDA Receptors and Impacts Downstream Signaling Linked to Antidepressant Effects
    Kavalali, Ege T.
    Monteggia, Lisa M.
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 (01) : 221 - 222
  • [38] Role of BDNF/mTORC1 Signaling in the Long-Lasting Antidepressant Effects of (2R,6R)-Hydroxynorketamine
    Fukumoto, Kenichi
    Kato, Taro
    Li, Xio-Yuan
    Duman, Ronald
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S196 - S197
  • [39] Target Deconvolution Studies of (2R,6R)-Hydroxynorketamine: An Elusive Search
    Bonaventura, Jordi
    Gomez, Juan L.
    Lam, Sherry
    Soto, Marta Sanchez
    Morris, Patrick J.
    Zanos, Panos
    Moaddel, Ruin
    Gould, Todd D.
    Sibley, David R.
    Thomas, Craig J.
    Zarate, Carlos A., Jr.
    Michaelides, Mike
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 194 - 194
  • [40] Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search
    Bonaventura, Jordi
    Gomez, Juan L.
    Carlton, Meghan L.
    Lam, Sherry
    Sanchez-Soto, Marta
    Morris, Patrick J.
    Moaddel, Ruin
    Kang, Hye Jin
    Zanos, Panos
    Gould, Todd D.
    Thomas, Craig J.
    Sibley, David R.
    Zarate, Carlos A., Jr.
    Michaelides, Michael
    MOLECULAR PSYCHIATRY, 2022, 27 (10) : 4144 - 4156
12345